In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET-Reference-Cited by-同舟云学术

In vivo 5-HT6 and 5-HT2A receptor availability in antipsychotic treated schizophrenia patients vs. unmedicated healthy humans measured with [11C]GSK215083 PET

Published:2020-01 Issue: Volume:295 Page:111007
ISSN:0925-4927
Container-title:Psychiatry Research: Neuroimaging
language:en
Short-container-title:Psychiatry Research: Neuroimaging

Author:

Radhakrishnan Rajiv,Matuskey David,Nabulsi Nabeel,Gaiser Edward,Gallezot Jean-Dominique,Henry Shannan,Planeta Beata,Lin Shu-fei,Ropchan Jim,Huang Yiyun,Carson Richard E,D'Souza Deepak Cyril

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Radiology, Nuclear Medicine and imaging,Neuroscience (miscellaneous)

Reference46 articles.

1. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs;Andreasen;Biol. Psychiatry,2010

2. Effect of idalopirdine as adjunct to cholinesterase inhibitors on change in cognition in patients with alzheimer disease: three randomized clinical trials;Atri;JAMA,2018

3. Serotonergic 5-HT6 receptor antagonists: heterocyclic chemistry and potential therapeutic significance;Bali;Curr. Top. Med. Chem.,2015

4. Lack of benefit with idalopirdine for alzheimer disease: another therapeutic failure in a complex disease process;Bennett;JAMA,2018

5. 5-HT6 pharmacology inconsistencies;Borsini;Pharmacol. Biochem. Behav.,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized gray matter morphological abnormalities uncover two robust transdiagnostic biotypes;Journal of Affective Disorders;2024-11

2. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics;The World Journal of Biological Psychiatry;2024-09

3. Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies;Nature Biomedical Engineering;2024-08-05

4. Update Lessons from Positron Emission Tomography Imaging Part I: A Systematic Critical Review on Therapeutic Plasma Concentrations of Antipsychotics;Therapeutic Drug Monitoring;2023-11-27

5. Convergent functional effects of antidepressants in major depressive disorder: a neuroimaging meta-analysis;2023-11-27